Delivery Order SPE2DR25D9305-SPE2DR26FSHD7
- Not listed
- The Defense Logistics Agency awarded a $16,900.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, which carries an ultimate completion date of January 7, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $30,674.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued January 12, 2026, with an ultimate completion date of February 3, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is...
- The Defense Logistics Agency awarded a $18,404.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ml, with an ultimate completion date of February 11, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,067.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,450.43 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, issued December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award...
- The Defense Logistics Agency awarded a delivery order valued at $11,267.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The contract, designated as delivery order 4570008681, carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of December 2, 2025. This delivery order was issued under DMS Pharmaceutical Group's recently...
- The Defense Logistics Agency awarded a delivery order valued at $22,534.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in the open market. This delivery order is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- The Defense Logistics Agency awarded a $3,727.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PHOTREXA Cross-Linking Kit in 6ml quantities. The contract is valued at $14,910.04 under a firm fixed-price arrangement with an ultimate completion date of June 25, 2025. This delivery order was issued without set-aside designation and represents a continuation of DMS Pharmaceutical Group's significant role...
- SPE2DR25D9305Indefinite Delivery Contract
- SPE2DR25D9305-SPE2DR26FSHD7Delivery Order
The Defense Logistics Agency awarded a $9,202.35 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6mL. The contract, issued on January 27, 2026, with a firm fixed-price structure and ultimate completion date of February 18, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will occur in Park Ridge, Illinois. DMS Pharmaceutical Group operates under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply the Department of Defense's medical needs globally. The company holds a single-award Indefinite Delivery Contract (SPE2DR) valued at $499,999,999 with a completion date of December 31, 2036, which enables DLA to issue delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to support military healthcare facilities worldwide. The current delivery order for Photrexa represents one of numerous orders the contractor has fulfilled under this broader pharmaceutical supply framework, reflecting its established performance as a critical supplier within the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 1/26/26 |